| Kirsy Acosta-ortiz, CRNA | |
|
11375 Cortez Blvd, Brooksville, FL 34613-5409 | |
| (352) 597-6363 | |
| (352) 379-7489 |
| Full Name | Kirsy Acosta-ortiz |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 25 Years |
| Location | 11375 Cortez Blvd, Brooksville, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861413528 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN9194555 (Florida) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | ARNP9194555 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ams National Llc | 3870813025 | 203 |
| The Fort Defiance Indian Hospital Board, Incorporation | 0941336697 | 144 |
News Archive
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
› Verified 2 days ago
| Entity Name | Anesthesiologist Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306889910 PECOS PAC ID: 8921910027 Enrollment ID: O20031105000469 |
News Archive
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
› Verified 2 days ago
| Entity Name | Gulf-to-bay Anesthesiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720039746 PECOS PAC ID: 5092628156 Enrollment ID: O20031106000250 |
News Archive
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
› Verified 2 days ago
| Entity Name | Florida Clinical Practice Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063463768 PECOS PAC ID: 0345146254 Enrollment ID: O20031211000099 |
News Archive
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
› Verified 2 days ago
| Entity Name | Bay Anesthesia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831130889 PECOS PAC ID: 6002716792 Enrollment ID: O20040109000711 |
News Archive
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
› Verified 2 days ago
| Entity Name | Advanced Anesthesia Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811056153 PECOS PAC ID: 3173518966 Enrollment ID: O20040420000472 |
News Archive
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
› Verified 2 days ago
| Entity Name | North Tampa Anesthesia Consultants |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144216433 PECOS PAC ID: 2860474483 Enrollment ID: O20040607000186 |
News Archive
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
› Verified 2 days ago
| Entity Name | Ams National Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316330830 PECOS PAC ID: 3870813025 Enrollment ID: O20150529000613 |
News Archive
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
› Verified 2 days ago
| Entity Name | American Anesthesiology Services Of Florida Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508318387 PECOS PAC ID: 1850674540 Enrollment ID: O20170202001989 |
News Archive
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kirsy Acosta-ortiz, CRNA 11375 Cortez Blvd, Brooksville, FL 34613-5409 Ph: () - | Kirsy Acosta-ortiz, CRNA 11375 Cortez Blvd, Brooksville, FL 34613-5409 Ph: (352) 597-6363 |
News Archive
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment of high blood pressure, which affects about one in three adults in the United States.
CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office.
Jessica Damoiseaux, Ph.D., an associate professor with the Institute of Gerontology at Wayne State University, recently published the results of a three-year study of cognitive changes in older adults.
AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.
› Verified 2 days ago
Nicole Marie Dibella, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 352-596-6632 | |
Gail Shue, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 15205 Cortez Blvd, Brooksville, FL 34613 Phone: 352-597-7744 Fax: 352-597-7797 | |
Angela Marie Bacon, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 352-596-6632 | |
Arnold Szabo, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 352-596-6632 | |
Rodney Holcomb, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 352-544-7112 Fax: 352-688-7224 | |
Mrs. Lorna Marie Gonzalez, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 352-596-6632 Fax: 352-688-7224 | |
Scott Lamar Babcock, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 15205 Cortez Blvd, Brooksville, FL 34613 Phone: 352-597-7744 Fax: 352-597-7797 |